CN1582145A - 含有二甲双胍的缓释药物组合物 - Google Patents

含有二甲双胍的缓释药物组合物 Download PDF

Info

Publication number
CN1582145A
CN1582145A CNA02822180XA CN02822180A CN1582145A CN 1582145 A CN1582145 A CN 1582145A CN A02822180X A CNA02822180X A CN A02822180XA CN 02822180 A CN02822180 A CN 02822180A CN 1582145 A CN1582145 A CN 1582145A
Authority
CN
China
Prior art keywords
pharmaceutical composition
metformin
cellulose
moisture
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA02822180XA
Other languages
English (en)
Chinese (zh)
Inventor
D·莫帕尼
A·马丹
V·K·阿罗拉
R·马利克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of CN1582145A publication Critical patent/CN1582145A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CNA02822180XA 2001-09-28 2002-09-27 含有二甲双胍的缓释药物组合物 Pending CN1582145A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1002DE2001 IN192180B (enExample) 2001-09-28 2001-09-28
IN1002/DEL/2001 2001-09-28

Publications (1)

Publication Number Publication Date
CN1582145A true CN1582145A (zh) 2005-02-16

Family

ID=11097117

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA02822180XA Pending CN1582145A (zh) 2001-09-28 2002-09-27 含有二甲双胍的缓释药物组合物

Country Status (12)

Country Link
US (1) US20040059001A1 (enExample)
EP (1) EP1434568A1 (enExample)
JP (1) JP2005507896A (enExample)
KR (1) KR20040063900A (enExample)
CN (1) CN1582145A (enExample)
AR (1) AR037326A1 (enExample)
BR (1) BR0212931A (enExample)
EA (1) EA200400487A1 (enExample)
IN (1) IN192180B (enExample)
MX (1) MXPA04002910A (enExample)
WO (1) WO2003028704A1 (enExample)
ZA (1) ZA200402532B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105152983A (zh) * 2007-01-29 2015-12-16 韩诺生物制药株式会社 N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
CN106138020A (zh) * 2015-04-03 2016-11-23 中国人民解放军第三军医大学第三附属医院 双胍类药物在制备预防或减弱肺纤维化的药物中的应用
WO2018177318A1 (zh) * 2017-04-01 2018-10-04 重庆康刻尔制药有限公司 一种盐酸二甲双胍缓释片及其制备方法
CN111588701A (zh) * 2020-05-25 2020-08-28 上海普康药业有限公司 一种盐酸二甲双胍缓释片及其制备方法

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911781B2 (en) 2002-06-17 2014-12-16 Inventia Healthcare Private Limited Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
CN1805738A (zh) * 2003-06-16 2006-07-19 兰贝克赛实验室有限公司 持续释放的二甲双胍片剂
WO2005092293A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Formulations of metformin
WO2006038226A2 (en) * 2004-10-08 2006-04-13 Rubicon Research Pvt. Ltd. Process for making a highly compressible controlled delivery compositions of metformin
RS51271B (sr) * 2004-10-19 2010-12-31 Krka Tovarna Zdravil D.D. Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
WO2006082523A2 (en) * 2005-01-25 2006-08-10 Aurobindo Pharma Limited Pharmaceutical sustained release composition of metformin
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
BRPI0608609A2 (pt) * 2005-05-10 2010-01-19 Novartis Ag processo de extrusço para preparaÇço de composiÇÕes com compostos terapÊuticos fracamente compressÍveis
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
WO2007056205A2 (en) * 2005-11-04 2007-05-18 Eastman Chemical Company Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
BRPI0605967A (pt) * 2006-12-20 2008-08-12 Medley S A Ind Farmaceutica composição farmacêutica de liberação controlada, forma farmacêutica de liberação controlada e processo para obtenção de forma farmacêutica
KR101597004B1 (ko) 2013-07-25 2016-02-23 씨제이헬스케어 주식회사 서방형 메트포르민과 속방형 HMG-CoA 환원효소 억제제를 포함하는 복합제제
WO2021133046A1 (ko) * 2019-12-23 2021-07-01 주식회사 대웅제약 메트포르민 서방성 제제 및 이의 제조 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813064D0 (en) * 1988-06-02 1988-07-06 Euro Celtique Sa Controlled release dosage forms having defined water content
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
CA2312990C (en) * 1997-12-08 2008-04-29 Bristol-Myers Squibb Company Novel salts of metformin and method
CN1203846C (zh) * 1998-03-19 2005-06-01 布里斯托尔-迈尔斯斯奎布公司 高溶解性药物的双相控释递送系统和方法
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105152983A (zh) * 2007-01-29 2015-12-16 韩诺生物制药株式会社 N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
CN106138020A (zh) * 2015-04-03 2016-11-23 中国人民解放军第三军医大学第三附属医院 双胍类药物在制备预防或减弱肺纤维化的药物中的应用
WO2018177318A1 (zh) * 2017-04-01 2018-10-04 重庆康刻尔制药有限公司 一种盐酸二甲双胍缓释片及其制备方法
CN111588701A (zh) * 2020-05-25 2020-08-28 上海普康药业有限公司 一种盐酸二甲双胍缓释片及其制备方法
CN111588701B (zh) * 2020-05-25 2021-04-23 上海普康药业有限公司 一种盐酸二甲双胍缓释片及其制备方法

Also Published As

Publication number Publication date
ZA200402532B (en) 2005-01-04
AR037326A1 (es) 2004-11-03
EP1434568A1 (en) 2004-07-07
JP2005507896A (ja) 2005-03-24
WO2003028704A1 (en) 2003-04-10
EA200400487A1 (ru) 2004-10-28
US20040059001A1 (en) 2004-03-25
KR20040063900A (ko) 2004-07-14
MXPA04002910A (es) 2004-07-05
IN192180B (enExample) 2004-03-06
BR0212931A (pt) 2004-10-13

Similar Documents

Publication Publication Date Title
CN1582145A (zh) 含有二甲双胍的缓释药物组合物
CN1805738A (zh) 持续释放的二甲双胍片剂
US20110091547A1 (en) Pharmaceutical Compositions Comprising Brivaracetam
US20060165779A1 (en) Novel method stabilizing bupropion hydrochloride tablets
KR20110116006A (ko) 제어 방출형 약학적 제제 또는 식품 제제 및 이의 제조 방법
EP1305050A2 (en) Improved oral dosage formulations
CN102204911B (zh) 一种盐酸莫西沙星药物组合物及其制备方法
CN1700910A (zh) 甲福明控释片剂
EA006008B1 (ru) Способ получения таблеток из фармацевтически активных веществ
CN1074134A (zh) 药用粒化组合物及其制备方法
WO1999058114A1 (en) Sustained release tablets, additive compositions therefor and process for producing the same
EP1713452B1 (en) Sustained release pharmaceutical composition of indapamide
KR101033975B1 (ko) 직접압축법을 이용한 발사르탄 함유 고형 경구 제형의 제조방법 및 이에 따라 제조된 고형 경구 제형
CN101808630A (zh) 阿利吉仑的盖仑制剂
CN116999401A (zh) 一种奥美沙坦酯缓释分散片
CN107320440B (zh) 含萝卜硫素胃滞留组合物及其制备方法
CN114748438B (zh) 一种阿伐普利尼片组合物及其制备方法
CN112263555B (zh) 一种替米沙坦口崩片及其制备方法
AU2002334326A1 (en) Extended release pharmaceutical composition containing metformin
CN1842333A (zh) 口服缓释片剂
CN115068437B (zh) 一种苯溴马隆胶囊的制备方法
KR102897443B1 (ko) 제어 방출형 미라베그론 제제 및 이의 제조방법
CN1660222A (zh) 银杏叶提取物口崩片及制备方法
CN119235808A (zh) 一种甲氨蝶呤包衣片及其制备方法
CN1557306A (zh) 苦参素分散片

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication